| Literature DB >> 30945334 |
Shinya Iwasawa1, Kumiko Yanagi2, Atsuo Kikuchi1, Yasuko Kobayashi3,4, Kazuhiro Haginoya4,5, Hiroshi Matsumoto6, Kenji Kurosawa7, Masayuki Ochiai8, Yasunari Sakai8, Atsushi Fujita9, Noriko Miyake9, Tetsuya Niihori10, Matsuyuki Shirota11, Ryo Funayama12, Shigeaki Nonoyama6, Shouichi Ohga8, Hiroshi Kawame13, Keiko Nakayama12, Yoko Aoki10, Naomichi Matsumoto9, Tadashi Kaname2, Yoichi Matsubara2, Wataru Shoji14, Shigeo Kure1,13.
Abstract
c-Jun-amino-terminal kinase-interacting protein 3 (JIP3), encoded by MAPK8IP3, is an adaptor protein of the kinesin-1 complex and essential for axonal transport in neurons. However, an association between MAPK8IP3 variants and human disease has not been established. We identified 5 individuals from four families with recurrent de novo variants c.1732C>T (p.Arg578Cys) and c.3436C>T (p.Arg1146Cys) in MAPK8IP3. The core phenotype includes spastic diplegia, intellectual disability, cerebral atrophy, and corpus callosum hypoplasia. Zebrafish embryos overexpressing human mutant JIP3 showed axon varicosities of the posterior lateral line nerve, suggesting an adverse effect on the developing axons. Our results suggest that MAPK8IP3 variants cause a neurodevelopmental disease. ANN NEUROL 2019;85:927-933.Entities:
Year: 2019 PMID: 30945334 DOI: 10.1002/ana.25481
Source DB: PubMed Journal: Ann Neurol ISSN: 0364-5134 Impact factor: 10.422